艾華集團(603989.SH):控股股東減持可轉債合計72.147萬張
格隆匯6月23日丨艾華集團(603989.SH)公吿,2021年6月23日,公司接到控股股東艾華控股通知,2021年6月5日至2021年6月22日期間,艾華控股本次通過上海證券交易所交易系統減持其所持有的艾華轉債共計72.147萬張,佔發行總量的10.44%。
其中,公司控股股東通過上海證券交易所交易系統集中競價及大宗交易共計減持艾華轉債52.147萬張(佔發行總量的7.55%)後,通過一筆大宗交易方式減持艾華轉債20萬張(佔發行總量的2.89%),減持後艾華控股停止交易艾華轉債。
截至本公吿日,公司控股股東及其一致行動人合計持有艾華轉債184.224萬張,佔發行總量的26.66%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.